115 related articles for article (PubMed ID: 2679794)
1. Natural killer cell lysis of head and neck cancer.
Racz T; Sacks PG; Taylor DL; Schantz SP
Arch Otolaryngol Head Neck Surg; 1989 Nov; 115(11):1322-8. PubMed ID: 2679794
[TBL] [Abstract][Full Text] [Related]
2. Differential sensitivity of head and neck cancers to non-major histocompatibility-restricted killer cell activity.
Schantz SP; Racz T; Ordonez NG; Terry N; Taylor DL; Bugis S; Sacks PG
J Surg Res; 1990 Feb; 48(2):154-64. PubMed ID: 2106056
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of natural killer cell function and risk of metastatic poorly differentiated head and neck cancer.
Schantz SP; Ordonez NG
Nat Immun Cell Growth Regul; 1991; 10(5):278-88. PubMed ID: 1758468
[TBL] [Abstract][Full Text] [Related]
4. Production of lymphokine-activated lymphocytes. Lysis of human head and neck squamous cell carcinoma cell lines.
Alessi DM; Hutcherson RW; Mickel RA
Arch Otolaryngol Head Neck Surg; 1989 Jun; 115(6):725-30. PubMed ID: 2785809
[TBL] [Abstract][Full Text] [Related]
5. Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neck.
Sung MW; Yasumura S; Johnson JT; Van Dongen GA; Whiteside TL
Int J Cancer; 1995 Jun; 61(6):864-72. PubMed ID: 7790123
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
Sung MW; Johnson JT; Van Dongen G; Whiteside TL
Int J Cancer; 1996 May; 66(3):393-9. PubMed ID: 8621263
[TBL] [Abstract][Full Text] [Related]
7. Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines.
Kim MJ; Lee JC; Lee JJ; Kim S; Lee SG; Park SW; Sung MW; Heo DS
Tumour Biol; 2008; 29(1):28-34. PubMed ID: 18497546
[TBL] [Abstract][Full Text] [Related]
8. Identification of lymphocyte subsets and natural killer cells in head and neck cancers. An immunohistological study using monoclonal antibodies.
Harabuchi Y; Yamanaka N; Kataura A
Arch Otorhinolaryngol; 1985; 242(1):89-97. PubMed ID: 3899069
[TBL] [Abstract][Full Text] [Related]
9. Intracellular calcium changes associated with in vitro lymphokine-activated killer and natural killer cell cytotoxicity.
Burkey BB; Omann GM; Wolf GT
Arch Otolaryngol Head Neck Surg; 1991 Nov; 117(11):1281-6. PubMed ID: 1747234
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
11. Lysis of squamous cell carcinoma via antibody-dependent cellular cytotoxicity.
Koch WM; Richtsmeier WJ
Arch Otolaryngol Head Neck Surg; 1989 Jun; 115(6):669-76. PubMed ID: 2655665
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients.
Mickel RA; Kessler DJ; Taylor JM; Lichtenstein A
Cancer Res; 1988 Sep; 48(17):5017-22. PubMed ID: 3409231
[TBL] [Abstract][Full Text] [Related]
13. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
[TBL] [Abstract][Full Text] [Related]
14. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
[TBL] [Abstract][Full Text] [Related]
15. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
16. CD45 molecule cross-linking inhibits natural killer cell-mediated lysis independently of lytic triggering.
Starling GC; Hart DN
Immunology; 1990 Oct; 71(2):190-5. PubMed ID: 2146214
[TBL] [Abstract][Full Text] [Related]
17. The analysis of natural killer cell activity by flow cytometry.
Racz T; Sacks P; Van NT; Taylor DL; Young G; Bugis S; Savage HE; Schantz SP
Arch Otolaryngol Head Neck Surg; 1990 Apr; 116(4):440-6. PubMed ID: 1690553
[TBL] [Abstract][Full Text] [Related]
18. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.
Whiteside TL; Sung MW; Nagashima S; Chikamatsu K; Okada K; Vujanovic NL
Clin Cancer Res; 1998 May; 4(5):1135-45. PubMed ID: 9607570
[TBL] [Abstract][Full Text] [Related]
19. The role of apoptosis in antibody-dependent cell-mediated cytotoxicity against monolayers of human squamous cell carcinoma of the head and neck targets.
Sung MW; Nagashima S; Johnson JT; Van Dongen GA; Whiteside TL
Cell Immunol; 1996 Jul; 171(1):20-9. PubMed ID: 8660833
[TBL] [Abstract][Full Text] [Related]
20. Distribution of circulating natural killer cells and T lymphocytes in head and neck squamous cell carcinoma.
Böttcher A; Ostwald J; Guder E; Pau HW; Kramp B; Dommerich S
Auris Nasus Larynx; 2013 Apr; 40(2):216-21. PubMed ID: 22835730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
